Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 203883
Company: HOSPIRA
Company: HOSPIRA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ADENOSINE | ADENOSINE | 60MG/20ML (3MG/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | No | No |
| ADENOSINE | ADENOSINE | 90MG/30ML (3MG/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 03/24/2014 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 09/17/2015 | SUPPL-1 | Labeling-Package Insert |
Label is not available on this site. |